La Rosa Holdings SRTM

La Rosa Holdings: securities offering (amended)

Form
S-1/A
Filed
Importance
Routine
Document
S-1/A
Exhibit 10.96
Material contract
Exhibit 10.97
Material contract
Exhibit 10.98
Material contract
Exhibit 10.99
Material contract
Exhibit 10.100
Material contract
Exhibit 10.101
Material contract

Not explained yet; the original is on EDGAR.

Securities offering (amended)

Get an email when La Rosa Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

What changed since the last draft

22 changes since the S-1/A filed Jan 19, 2023

Compared with the S-1/A 0001575872-23-000097, filed Jan 19, 2023.

  1. New Offering terms

    Shares offered: 1,400,000

    Shares offered now 1,400,000; the earlier draft had not stated.

    From the filings

    Now

    We are offering 1,400,000 shares of our Common Stock, $0.0001 par value per share (the "Common Stock" or the "Securities"), in a firm commitment underwritten public offering (this "Offering") at an initial public offering price of $5.00 per share.
  2. New Offering terms

    Exchange: Nasdaq Capital Market

    Exchange now Nasdaq Capital Market; the earlier draft had not stated.

    From the filings

    Now

    Although we are a "controlled company" under the rules of the Nasdaq Capital Market, our board of directors will be composed of a majority of independent directors, and we will not take advantage of the "controlled company" exemptions provided under such rules.
  3. New Offering terms

    Ticker reserved: LRHC

    Ticker reserved now LRHC; the earlier draft had not stated.

    From the filings

    Now

    Market ("Nasdaq"), under the symbol "LRHC."
  4. New Share classes and governance

    Controlled company

    First mentioned in this draft.

    From the filings

    Now

    Although we are a "controlled company" under the rules of the Nasdaq Capital Market, our board of directors will be composed of a majority of independent directors, and we will not take advantage of the "controlled company" exemptions provided under such rules.
  5. New Sections

    New section: Prospectus summary

    SUMMARY OF THE OFFERING

    From the filings

    Now

    SUMMARY OF THE OFFERING
  6. New Sections

    New section: Risk factors

    in our Securities involves a high degree of risk and purchasers of our Securities may lose their entire investment.

    From the filings

    Now

    in our Securities involves a high degree of risk and purchasers of our Securities may lose their entire investment. See "Risk Factors" starting on page 17 and the other information included and incorporated by reference into this prospectus for a discussion of risk factors you should carefully consider before deciding to invest in our Securities.
  7. New Sections

    New section: Forward-looking statements

    prospectus contains "forward-looking statements." Forward-looking statements reflect the current view about future events.

    From the filings

    Now

    prospectus contains "forward-looking statements." Forward-looking statements reflect the current view about future events.
  8. New Sections

    New section: Business

    disruptions due to the pandemic may continue, particularly if stringent mitigation actions by government authorities are put in place or remain in place for a significant amount of time.

    From the filings

    Now

    disruptions due to the pandemic may continue, particularly if stringent mitigation actions by government authorities are put in place or remain in place for a significant amount of time. The future impact of the COVID-19 pandemic on our liquidity, financial condition and results of operations is unknown, and its impact may be variable over time as government regulations, market conditions and consumer behavior changes in response to developments with respect to the pandemic.
  9. New Sections

    New section: Use of proceeds

    estimate that the net proceeds to us from the sale of the Common Stock offered by us will be approximately $4,640,000 based on an initial public offering price of $5.00 per share and after deducting estimated…

    From the filings

    Now

    estimate that the net proceeds to us from the sale of the Common Stock offered by us will be approximately $4,640,000 based on an initial public offering price of $5.00 per share and after deducting estimated underwriting discounts and commissions and estimated offering expenses. If the underwriters' option to purchase additional shares of Common Stock in this Offering is exercised in full, we estimate that our net proceeds will be approximately $5,595,000. We will not receive any of the proceeds from the sale of our Common Stock by the Selling Stockholders or the Representative with respect to the Common Stock issuable upon exercise of the Representative's Warrant. However, upon any exercise of the Representative's Warrant, we will receive cash proceeds per share equal to the exercise price of the Representative's Warrant which is $5.50 per share (110% of the public offering price per share). If all 70,000 shares of Common Stock exercisable under the Representative's Warrant are exercised, the aggregate gross proceeds from the exercise of those warrants would be approximately $385,000 (or $442,750 if the Representative exercises the over-allotment option in full).
  10. New Sections

    New section: Capitalization

    interest outstanding as of December 31, 2022, net of deferred financing fees of $20,221, is $677,600, which includes accrued interest of $91,821 classified as "Accrued expense" on the balance sheet.

    From the filings

    Now

    interest outstanding as of December 31, 2022, net of deferred financing fees of $20,221, is $677,600, which includes accrued interest of $91,821 classified as "Accrued expense" on the balance sheet. Subsequent to December 31, 2022, the Company exchanged convertible debt with an outstanding balance of $341,580, including accrued interest of $40,580, for 337 shares of Series A Preferred Stock. The value of the remining convertible debt plus accrued interest on the estimated Offering date of May 12, 2023 is excepted to be $379,813, with all deferred financing fees fully amortized, and is expected to convert into 94,947 shares at the offering price of $5.00. The "Unaudited pro forma" column reflects the 92,322 shares that would be issued as of December 31, 2022 for the unexchanged convertible notes and the "Unaudited pro forma as adjusted" column reflects the 94,947 shares that are expected to be issued on the Offering date.
  11. New Sections

    New section: Dilution

    you invest in our Common Stock in this Offering, your interest in our Common Stock will be diluted to the extent of the difference between the initial public offering price per share of our Common Stock (calculated for…

    From the filings

    Now

    you invest in our Common Stock in this Offering, your interest in our Common Stock will be diluted to the extent of the difference between the initial public offering price per share of our Common Stock (calculated for purposes of this discussion to be the initial public offering price of one share) and the pro forma as adjusted net tangible book value per share of our Common Stock after this Offering.
  12. New Sections

    New section: Dividend policy

    2020, we paid dividends to the members of Coaching, CRE, Franchising, Property Management and Realty in the amount of $559,928.

    From the filings

    Now

    2020, we paid dividends to the members of Coaching, CRE, Franchising, Property Management and Realty in the amount of $559,928.

and 10 more, in the redline below

Show the redline

Section by section. Added words and removed words against the earlier filing.

Cover page 70 changes

Registration No. 333-264372

Washington, D.C. 20549

REGISTRATION STATEMENT

LA ROSA HOLDINGS CORP.

As filed with the U.S. Securities and Exchange Commission

Commission on April 26, 2023.

SECURITIES AND EXCHANGE COMMISSION

UNDER THE SECURITIES ACT OF 1933

(Exact name of registrant as specified in its charter)

(State or other jurisdiction of

4 unchanged paragraphs

1420 Celebration Blvd., 2nd Floor

Celebration, FL 34747

Chief Executive Officer

1420 Celebration Blvd., 2nd Floor

Celebration, FL 34747

(Name, address, including zip code and telephone number,

including area code, of agent for service)

Ross D. Carmel, Esq.

Celebration Blvd., 2 nd Floor

including zip code and telephone number, including area code, of registrant's principal executive offices)

Celebration Blvd., 2 nd Floor

address, including zip code and telephone number, including area code, of agent for service)

Please send copies of all communications to:

1 unchanged paragraph

55 West 39th Street, 18th Floor

M. Ali Panjwani, Esq.

55 West 39 th Street, 4th Floor

Approximate date of commencement of proposed sale to the public:

1 unchanged paragraph

If any of the securities being

registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended (the "Securities Act"), check the following box.

If this form is filed to register

additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities

Act registration statement number of the earlier effective registration statement for the same offering.

If this form is a post-effective

amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.

If this form is a post-effective

amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.

Indicate by check mark whether

any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended (the "Securities Act"), check the following box. ☐ this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer,"

the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

1 unchanged paragraph

If an emerging growth company,

The Registrant hereby amends this registration

Act of 1933, or until this registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.

La Rosa Holdings Corp. is filing this amendment (this

"Amendment No. 6") to its registration statement on Form S-1 (File No. 333-264372) as an exhibits-only filing. Accordingly, this Amendment No. 6 consists only of the facing page, this explanatory note, Item 16(a) of Part II of the registration statement, the signature page to the registration statement, and the filed exhibit. The remainder of the registration statement is unchanged and has therefore been omitted.

INFORMATION NOT REQUIRED IN PROSPECTUS

Non-accelerated filer x ☒

Smaller reporting company x ☒

Emerging growth company x ☒

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, or until this registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.

information in this prospectus is not complete and may be changed. Neither we nor the selling stockholders may sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

Subject to Completion, Dated April

Shares of Common Stock

This is the initial public offering

by La Rosa Holdings Corp., a Nevada corporation (the "Company"). We are offering 1,400,000 shares of our Common Stock, $0.0001 par value per share (the "Common Stock" or the "Securities"), in a firm commitment underwritten public offering (this "Offering") at an initial public offering price of $5.00 per share.

We have also registered for

public sale: (i) 70,000 shares of our Common Stock issuable to the representative of the underwriters ("Representative")

upon the exercise of a warrant to be issued to the Representative (or 80,500 shares if the Representative exercises the over-allotment option in full); and (ii) 2,363,466 shares of Common Stock held by 161 selling stockholders (the Representative and the selling stockholders referred to herein as the "Selling Stockholders"). We will not receive any of the proceeds from the sale of Common Stock by the Selling Stockholders. However, upon any exercise of the warrant held by the Representative (the "Representative's

Warrant"), we will receive cash proceeds per share equal to the exercise price of such warrant. The shares to be sold by the Selling

Stockholders (the "Selling Stockholder Shares") will not be purchased by the underwriters or otherwise included in the underwritten offering of our Common Stock in this initial public offering. The Selling Stockholders may sell or otherwise dispose of their shares in a number of different ways and at varying prices, but will not sell any Selling Stockholder Shares until after the closing of this

Offering. See "Selling Stockholders-Plan of Distribution." We will pay all expenses (other than discounts, concessions, commissions and similar selling expenses, if any) relating to the registration of the Selling Stockholders' shares of Common Stock with the Securities and Exchange Commission.

has been no public market our Common Stock prior to this Offering. Our Common Stock has been approved for listing on the Nasdaq Capital

Market ("Nasdaq"), under the symbol "LRHC."

Following the completion of this

Offering, our Founder, Chairman of the board of directors and Chief Executive Officer, Mr. Joseph La Rosa, will control 82.8% of the total voting power of our voting capital stock with respect to director elections and all other matters. Although we are a "controlled company" under the rules of the Nasdaq Capital Market, our board of directors will be composed of a majority of independent directors, and we will not take advantage of the "controlled company" exemptions provided under such rules. Please see "Security

Ownership of Certain Beneficial Owners and Management."

in our Securities involves a high degree of risk. See "Risk Factors" beginning on page 17 of this prospectus for a discussion of information that should be considered in connection with an investment in our Securities.

are an "emerging growth company" as that term is used in the Jumpstart Our Business Startups Act of 2012 (the "JOBS

Act") and, as such, we have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings. See "Prospectus Summary - Implications of Being an Emerging Growth Company."

the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.

Only in this filing: Prospectus summary, Risk factors, Forward-looking statements, Business, Use of proceeds, Capitalization, Dilution, Dividend policy, Market for the common stock, MD&A, Properties, Management, Principal stockholders, Plan of distribution, Notes to the financial statements, Financial statements, Note 1: DESCRIPTION OF BUSINESS AND NATURE OF OPERATIONS, Note 2: SUMMARY OF SIGNIFICANT ACCOUNTING, Note 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued), Note 4: RELATED PARTY TRANSACTIONS, Note 5: COMMITMENTS AND CONTINGENCIES, Legal proceedings, Note 6: DEBT, Note 6: DEBT (continued), Note 7: EQUITY, Note 7: EQUITY (continued), Note 8: SEGMENTS, Note 5: Real Estate Brokerage Services, Note 8: SEGMENTS (continued), Note 9: INCOME TAXES, Note 10: SUBSEQUENT EVENTS, Note 3: CONCENTRATIONS OF BUSINESS AND CREDIT RISK, Note 4: FIXED ASSETS, Note 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Note 5: COMMITMENTS AND CONTINGENCIES (continued), Note 13: Other Expenses of Issuance and Distribution, Note 14: Indemnification of Directors and Officers, Note 15: Recent Sales of Unregistered Securities, Note 16: Exhibits and Financial Statement Schedules, Note A: La Rosa*, Note R: White*

Only in the earlier filing: Exhibits

Compared by code from the two drafts’ text: offering terms first, then sections and risk factors added or removed, numbers that moved, and rewording. No model wrote this list. Not investment advice.

Similar companies

Companies of similar size in SIC 6531 and related industry codes: the same peer list as the financial tables.

Data on this page was fetched . The filing on SEC.gov is the record.